Pharsight

Drugs that contain Amlodipine Besylate; Hydrochlorothiazide; Valsartan

1. Exforge Hct patents expiration

EXFORGE HCT's oppositions filed in EPO
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5399578

(Pediatric)

NOVARTIS Acyl compounds
Sep, 2012

(11 years ago)

US6294197 NOVARTIS Solid oral dosage forms of valsartan
Jun, 2017

(6 years ago)

US6294197

(Pediatric)

NOVARTIS Solid oral dosage forms of valsartan
Dec, 2017

(6 years ago)

US8101599 NOVARTIS Pharmaceutical composition containing anti-hypertensive agents
May, 2023

(1 year, 4 days ago)

US8475839 NOVARTIS Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
May, 2023

(1 year, 4 days ago)

US8475839

(Pediatric)

NOVARTIS Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
Nov, 2023

(6 months ago)

Drug Exclusivity Drug Exclusivity Expiration
New Combination(NC) Apr 30, 2012

Market Authorisation Date: 30 April, 2009

Treatment: Treatment of hypertension

Dosage: TABLET;ORAL

How can I launch a generic of EXFORGE HCT before it's drug patent expiration?
More Information on Dosage

EXFORGE HCT family patents

Family Patents